Daily Pharma News

Dated daily entries, newest first. Each post carries the full article for that day.

Swipe or scroll sideways through the latest editions, or jump between dates with the Newer and Older links on each card.

29 October 2026

NPPA Revises MRPs for 543 Anti-Cancer Medicine Brands in India, Effective 9 November 2026

Read edition

Older →

28 October 2026

CDSCO Counterfeit Defitelio Alert in India: Falsified Defibrotide Batch 24GC01A Warning

Read edition

← Newer · Older →

27 October 2026

NPPA Caps Trade Margins on 137 Cancer Drugs in India: Prices May Fall up to 70 Percent from 9 November 2026

Read edition

← Newer · Older →

26 October 2026

USFDA Inspection at Lupin Goa Plant Ends With One Form 483 Observation: What It Means for Indian Pharma Manufacturing

Read edition

← Newer · Older →

25 October 2026

India pharma marketing rules review: Centre sets up panel to examine UCPMP 2024 and unethical practices

Read edition

← Newer · Older →

24 October 2026

Dr Reddy's Launches Obeda Pro and Obeda Plus After Original Obeda Supply Disruption

Read edition

← Newer · Older →

23 October 2026

Delhi Drug Control Report: Quality Lapses Found at 44 Factories and 1,807 Retail Outlets

Read edition

← Newer · Older →

22 October 2026

DCGI approves Dr Reddy's Zytorvi (toripalimab) for advanced esophageal cancer

Read edition

← Newer · Older →

21 October 2026

DCGI Questions NFI 2026: National Formulary of India Lists Drugs Without CDSCO Approval

Read edition

← Newer · Older →

20 October 2026

NPPA Caps Trade Margins at 30% on 137 Anti-Cancer Drugs: Prices May Fall up to 70% from November 9

Read edition

← Newer · Older →

19 October 2026

Gujarat Pharma Plant Reactor Explosion: Five Dead, Methylene Dichloride Leak at SynZeal Pharmachem, Bharuch

Read edition

← Newer · Older →

18 October 2026

NPPA caps trade margins on 137 anti-cancer drugs at 30% of MRP from November 9

Read edition

← Newer · Older →

17 October 2026

India Overhauls Drug Patent Guidelines to Curb Evergreening - Faster Entry for Cheap Generics

Read edition

← Newer · Older →

16 October 2026

CDSCO Waives Export NOC for Approved r-DNA Drugs Sold Under New Brand Names

Read edition

← Newer · Older →

15 October 2026

NIPER Raebareli and AstraZeneca partner to expand clinical trial sites across India

Read edition

← Newer · Older →

14 October 2026

Supreme Court questions drug price caps limited to cancer drugs

Read edition

← Newer · Older →

13 October 2026

TDB Funds AI Drug Discovery in India: Rs. 86 Crore 'VIGOR' Project with Peptris, Bengaluru

Read edition

← Newer · Older →

12 October 2026

India Proposes Strict Curbs on Prescription Drug Advertising by Retailers and Wholesalers

Read edition

← Newer · Older →

11 October 2026

Government caps trade margins at 30% on non-scheduled cancer drugs - prices may fall up to 70%

Read edition

← Newer · Older →

10 October 2026

GST Council Allows Pharma Companies to Claim Input Tax Credit (ITC) on Free Physician Samples and Expired Stock

Read edition

← Newer · Older →

9 October 2026

NPPA Proposes 30% Trade Margin Cap on Non-Scheduled Cancer Drugs — MRPs May Fall 20-70%

Read edition

← Newer · Older →

7 October 2026

Indian Pharmacopoeia 2026: 10th edition brings 121 new monographs and stronger drug quality standards

Read edition

← Newer · Older →

6 October 2026

Cough Syrup Warning India: CDSCO Recommends Red Label Warning for Children Under 4

Read edition

← Newer · Older →

5 October 2026

CDSCO Proposes Red Box Warnings on Cough Syrup Labels: No Use Below Age 4, Ban on Baby Pictures

Read edition

← Newer · Older →

4 October 2026

Zaynich NDA Accepted by US FDA: Historic First for an Indian-Developed New Chemical Entity

Read edition

← Newer · Older →

3 October 2026

CDSCO Approves NovaLead's Repurposed Esmolol Gel for Diabetic Foot Ulcer in India

Read edition

← Newer · Older →

2 October 2026

Supreme Court Seeks 16% MRP Cap on Medicines, Flags Huge Cancer Drug Markups

Read edition

← Newer · Older →

1 October 2026

CDSCO Restricts Vonoprazan 10 mg and 20 mg to Prescription-Only Sale in India

Read edition

← Newer · Older →

30 September 2026

Akums Drugs receives DCGI approval for Colchicine 0.5 mg tablets - India's first for cardiovascular risk reduction

Read edition

← Newer · Older →

29 September 2026

US 100% Pharma Tariffs Begin; India Gets Zero-Tariff Exemptions

Read edition

← Newer · Older →

28 September 2026

CDSCO tightens scrutiny of drugs containing narcotic, psychotropic substances

Read edition

← Newer · Older →

27 September 2026

India's pharma PLI schemes draw Rs 46,744 crore investment, Rs 4 lakh crore sales (INDIA - TrialMedPath, PIB/Dept. of Pharmaceuticals release)

Read edition

← Newer · Older →

26 September 2026

India orders crackdown on illegal nicotine pouches nationwide

Read edition

← Newer · Older →

25 September 2026

CDSCO: painkillers and antibiotics only on prescription (INDIA)

Read edition

← Newer

All editions

Meanwhile, the B.Pharm Semester 1 notes and the PDF library are live. Follow PharmacoLearn on Telegram and YouTube for updates.